首页> 外文期刊>Clinical Laboratory >Plasminogen activator inhibitor in patients with acute myocardial infarction and re-infarction in syndrome X
【24h】

Plasminogen activator inhibitor in patients with acute myocardial infarction and re-infarction in syndrome X

机译:X综合征急性心肌梗死和再梗死患者的纤溶酶原激活物抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

Plasminogen activator inhibitor was determined in myocardial infarction and re-infarction patient along with other parameters relevant for the Syndrome X, such as triglycerides, HDL-cholesterol and body mass index. Plasminogen activator inhibitor was determined in 58 patients with myocardial infarction and 18 patients with re- Infarction as well as in 57 healthy individuals. Significantly higher plaminogen activator inhibitor values were Found in re-infarction patients(6.53±0.39 U/mL)than in myocardial infarction patients(4.32±0.19 U/mL), Whereas the values were significantly higher in both groups in comparison to healthy individuals(2.81±0.74 U/mL).
机译:在心肌梗塞和再梗塞患者中测定了纤溶酶原激活物抑制剂,以及与X综合征相关的其他参数,例如甘油三酸酯,HDL-胆固醇和体重指数。在58例心肌梗死患者和18例再梗死患者以及57位健康个体中确定了纤溶酶原激活剂抑制剂。再梗死患者的纤溶酶原激活物抑制剂值(6.53±0.39 U / mL)明显高于心肌梗塞患者的(4.32±0.19 U / mL),而两组的值均显着高于健康个体( 2.81±0.74U / mL)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号